Data Re-analysis Shows Drug Finasteride May Reduce Risk For Most Prostate Cancers

A re-analysis of data from the landmark Prostate Cancer Prevention Trial finds that finasteride may reduce the risk for prostate cancer without boosting the odds of aggressive tumors. Adjusting for prostate volume, findings from landmark PCPT trial refute notion that drug boosts aggressive disease.

Read the whole article on Science Daily

More from Science Daily